BNP Paribas Financial Markets
KMTS

BNP Paribas Financial Markets’s Kestra Medical Technologies KMTS Stock Holding History

BNP Paribas Financial Markets’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
5,833
+1,439
+33% +$33.9K ﹤0.01% 4297
2025
Q4 		$117K Buy
4,394
+1,656
+60% +$42.6K ﹤0.01% 4313
2025
Q3 		$65.1K Buy
2,738
+1,638
+149% +$29.3K ﹤0.01% 4486
2025
Q2 		$18.2K Buy
+1,100
New +$24K ﹤0.01% 4646

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BNP Paribas Financial Markets's KMTS Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Kestra Medical Technologies (KMTS) stake by 33% in Q1 2026, buying an estimated $33.9K and bringing the position to 5,833 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #4297.

BNP Paribas Financial Markets first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $117K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • BNP Paribas Financial Markets held 5,833 shares of Kestra Medical Technologies worth $116K as of Q1 2026.
  • BNP Paribas Financial Markets bought 1,439 Kestra Medical Technologies shares in Q1 2026, an estimated $33.9K.
  • Kestra Medical Technologies made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4297 holding.
  • BNP Paribas Financial Markets first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • BNP Paribas Financial Markets's Kestra Medical Technologies position peaked at $117K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.